ATLANTA, GA--(Marketwired - March 12, 2015) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company") has announced that its subsidiary, LED Dental, has officially launched the new RIOSensor Intraoral Radiography System from RAY Co., Ltd. ("RAY"), a spin-off of Samsung Electronics, in the USA and Canada. As the latest dental imaging product from RAY, the RIOSensor embraces their history of providing high-quality, dependable technology platforms at a great value. The sensor officially premiered at the 150th Annual Chicago Midwinter Meeting last week.
Boasting true resolution of > 20 line pairs/mm, the RIOSensor provides image quality that is among the best in the industry. Built to deliver exceptional precision, RIOSensor images enhance the clinician's ability to improve radiographic diagnosis through a variety of custom filters to optimize sharpness and contrast for endodontics, periodontics and caries diagnosis.
"As clinicians, great image quality allows us to take our diagnostic capabilities to new heights," said Jeffrey Brooks, D.M.D., Vice President of Imaging for LED Dental. "However, image resolution alone is not enough to meet the demands of the modern dental practice. The RIOSensor also delivers enhanced durability and reliability to ensure a worry-free technology experience."
"RIOSensors provide a shock-absorption system for protection against drops, bites, and impacts, while a reinforced cable connection ensures durability at a point known for failure in other systems. The slim, proprietary cable design allows for extreme flexibility, while maintaining a high level of structural integrity to deliver years of worry-free use," added Dr. Brooks.
Doctors and patients alike can rely on the RIOSensor for both safety and comfort. The sensor housing is hermetically sealed and water-tight to allow for submersible disinfection, preventing cross-contamination and damage to the sensor's electronic components. The extremely flexible cable provides for effortless positioning based upon any diagnostic need. Available in two sizes with tapered edges, rounded corners and a thickness of only 5.3 mm, RIOSensors ensure patients maintain an exceptional level of comfort during examinations.
Simplicity and efficiency are the hallmarks of the RIOSensor's clinical workflow. Active acquisition technology means that the sensor is always ready to capture images when needed, with no user intervention required to ready the sensor. The direct USB connection makes in-line boxes, buttons, and controls obsolete. The process of obtaining high-quality images is as easy as positioning the sensor, taking the x-ray, and reviewing the image. And, integration with LED Imaging Software and a practice management system means clinical data is directly imported into the patient's chart.
Finally, the RIOSensor ensures exceptional peace of mind, with a standard two-year warranty and optional lifetime product maintenance with no deductible, allowing clinicians to keep their focus off of their technology and on caring for their patients.
"We are proud to be launching RAY's RIOSensor in both the US and Canadian dental markets, bringing a new level of quality, dependability, and diagnostic confidence backed by reliable technology to dental and specialty practices across North America," said Dr. David Gane, CEO of LED Medical Diagnostics. "With last year's very successful entry of the RAYSCAN Alpha Extraoral Imaging system into the dental imaging market, developing great intraoral imaging technology is the next logical progression for RAY."
"LED Dental has continued to be our trusted partner in delivering imaging solutions to the U.S. and Canadian markets," adds Dr. Sangchul Lee, CEO of RAY Company "We are excited to further that relationship with our latest product release."
For more information on LED Dental and the launch of the new Samsung RIOSensor, please visit www.leddental.com or call 844.952.7327.
About RAY (RAY Company, Ltd.)
Since 2004, RAY Company, Ltd. has specialized in researching, developing and producing high-quality digital imaging systems for the medical and dental industries. Due to the company's development of superior imaging technology, RAY became a subsidiary of worldwide technology leader Samsung Electronics Co., Ltd, in 2010. Under the Samsung brand, RAY launched the RAYSCAN Alpha - Expert in 2012 and rapidly penetrated the US market in 2014. With the success of the RAYSCAN Alpha, RAY made the strategic decision to become an independent imaging company in 2015, singularly focused on its future as a leader in the worldwide dental imaging market.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.